To enact the pharmacy benefit manager compensation reform

This bill reforms how pharmacy benefit managers (PBMs) are compensated in Massachusetts. It prohibits PBMs from earning income from services they provide to health insurers beyond a clearly defined management fee. The bill bans spread pricing, where PBMs charge more than the actual cost of drugs plus their fee. It requires annual certifications of compliance and allows for audits by the state. Confidential information gathered during audits must be protected. If a PBM breaks these rules, they could face penalties. The bill also allows the state to create regulations to enforce these rules.

Supporters of this bill might highlight that it enhances transparency and fairness in drug pricing. By banning spread pricing, it reduces costs for consumers and insurers. The bill's requirement for annual certifications and audits ensures accountability, potentially leading to lower healthcare costs. It puts patient and health plan interests at the forefront, protecting consumers from hidden fees.

Critics might argue that the bill imposes stringent regulations on pharmacy benefit managers, possibly leading to increased administrative costs. They may claim that the restrictions on PBM earnings could reduce competition or innovation in managing prescription drug benefits. There is also concern that these reforms might not effectively reduce drug prices and could disrupt existing contractual arrangements.